Literature DB >> 2999294

Circadian regulation of retinomotor movements. I. Interaction of melatonin and dopamine in the control of cone length.

M E Pierce, J C Besharse.   

Abstract

In lower vertebrates, cone retinomotor movements occur in response to changes in lighting conditions and to an endogenous circadian clock. In the light, cone myoids contract, while in the dark, they elongate. In order to test the hypothesis that melatonin and dopamine may be involved in the regulation of cone movement, we have used an in vitro eyecup preparation from Xenopus laevis that sustains light- and dark-adaptive cone retinomotor movement. Melatonin mimics darkness by causing cone elongation. Dark- and melatonin-induced cone elongation are blocked by dopamine. Dopamine also stimulates cone contraction in dark-adapted eyecups. The effect of dopamine appears to be mediated specifically by a dopamine receptor, possibly of the D2 type. The dopamine agonist apomorphine and the putative D2 agonist LY171555 induced cone contraction. In contrast, the putative D1 agonist SKF38393-A and specific alpha 1-, alpha 2-, and beta-adrenergic receptor agonists were without effect. Furthermore, the dopamine antagonist spiroperidol not only blocked light-induced cone contraction, but also stimulated cone elongation in the light. These results suggest that dopamine is part of the light signal for cone contraction, and that its suppression is part of the dark signal for cone elongation. Melatonin may affect cone movement indirectly through its influence on the dopaminergic system.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2999294      PMCID: PMC2228813          DOI: 10.1085/jgp.86.5.671

Source DB:  PubMed          Journal:  J Gen Physiol        ISSN: 0022-1295            Impact factor:   4.086


  54 in total

1.  Circadian regulation of nocturnin transcription by phosphorylated CREB in Xenopus retinal photoreceptor cells.

Authors:  Xiaorong Liu; Carla B Green
Journal:  Mol Cell Biol       Date:  2002-11       Impact factor: 4.272

2.  Melatonin MT-1-receptor immunoreactivity in the human eye.

Authors:  P Meyer; M Pache; K U Loeffler; L Brydon; R Jockers; J Flammer; A Wirz-Justice; E Savaskan
Journal:  Br J Ophthalmol       Date:  2002-09       Impact factor: 4.638

3.  Melatonin modulates the neural activity in photosensory pineal organ of the trout: evidence for endocrine-neuronal interactions.

Authors:  H Meissl; C Martin; M Tabata
Journal:  J Comp Physiol A       Date:  1990-11       Impact factor: 1.836

4.  Tyrosine phosphorylation of cGMP-gated ion channels is under circadian control in chick retina photoreceptors.

Authors:  Kwon-Seok Chae; Gladys Y-P Ko; Stuart E Dryer
Journal:  Invest Ophthalmol Vis Sci       Date:  2007-02       Impact factor: 4.799

5.  D2 dopamine receptors in the human retina: cloning of cDNA and localization of mRNA.

Authors:  A Dearry; P Falardeau; C Shores; M G Caron
Journal:  Cell Mol Neurobiol       Date:  1991-10       Impact factor: 5.046

6.  The expression of L-type voltage-gated calcium channels in retinal photoreceptors is under circadian control.

Authors:  Michael L Ko; Yilin Liu; Stuart E Dryer; Gladys Y-P Ko
Journal:  J Neurochem       Date:  2007-08-07       Impact factor: 5.372

7.  Circadian regulation of retinoschisin in the chick retina.

Authors:  Michael L Ko; Yilin Liu; Liheng Shi; Dorothy Trump; Gladys Y-P Ko
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-04       Impact factor: 4.799

Review 8.  Circadian regulation in the retina: From molecules to network.

Authors:  Gladys Y-P Ko
Journal:  Eur J Neurosci       Date:  2018-10-24       Impact factor: 3.386

9.  Dopamine in the Turkey retina-an impact of environmental light, circadian clock, and melatonin.

Authors:  Anna Lorenc-Duda; Małgorzata Berezińska; Anna Urbańska; Krystyna Gołembiowska; Jolanta B Zawilska
Journal:  J Mol Neurosci       Date:  2008-10-25       Impact factor: 3.444

10.  Photoreceptor coupling is controlled by connexin 35 phosphorylation in zebrafish retina.

Authors:  Hongyan Li; Alice Z Chuang; John O'Brien
Journal:  J Neurosci       Date:  2009-12-02       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.